Pescovitz MD - Search Results

1

Distinct gene expression pathways in islets from individuals with short- and long-duration type 1 diabetes.

Mastracci TL, Turatsinze JV, Book BK, Restrepo IA, Pugia MJ, Wiebke EA, Pescovitz MD, Eizirik DL, Mirmira RG. Mastracci TL, et al. Among authors: pescovitz md. Diabetes Obes Metab. 2018 Aug;20(8):1859-1867. doi: 10.1111/dom.13298. Epub 2018 Apr 16. Diabetes Obes Metab. 2018. PMID: 29569324 Free article.

2

Differences in alloimmune response between elderly and young mice.

Book BK, Volz MA, Ward EK, Eckert GJ, Pescovitz MD, Wiebke EA. Book BK, et al. Among authors: pescovitz md. Transplant Proc. 2013 Jun;45(5):1838-41. doi: 10.1016/j.transproceed.2013.01.006. Transplant Proc. 2013. PMID: 23769054

3

Removal of therapeutic anti-lymphocyte antibodies from human sera prior to anti-human leukocyte antibody testing.

Bearden CM, Book BK, Sidner RA, Pescovitz MD. Bearden CM, et al. Among authors: pescovitz md. J Immunol Methods. 2005 May;300(1-2):192-9. doi: 10.1016/j.jim.2005.03.001. Epub 2005 Apr 9. J Immunol Methods. 2005. PMID: 15896799

4

Utility of HbA1c in the detection of subclinical post renal transplant diabetes.

Hoban R, Gielda B, Temkit M, Saha C, Book BK, Baker E, Pescovitz MD. Hoban R, et al. Among authors: pescovitz md. Transplantation. 2006 Feb 15;81(3):379-83. doi: 10.1097/01.tp.0000188622.00840.13. Transplantation. 2006. PMID: 16477224

5

Depletion of the chimeric drug Rituximab from biological samples.

Book BK, Pescovitz MD, Guo L, Wiebke EA. Book BK, et al. Among authors: pescovitz md. Hum Immunol. 2017 Jul-Aug;78(7-8):500-502. doi: 10.1016/j.humimm.2017.05.003. Epub 2017 May 18. Hum Immunol. 2017. PMID: 28528708 Free article. No abstract available.

6

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics.

Vieira CA, Agarwal A, Book BK, Sidner RA, Bearden CM, Gebel HM, Roggero AL, Fineberg NS, Taber T, Kraus MA, Pescovitz MD. Vieira CA, et al. Among authors: pescovitz md. Transplantation. 2004 Feb 27;77(4):542-8. doi: 10.1097/01.tp.0000112934.12622.2b. Transplantation. 2004. PMID: 15084932

7

Rituximab, anti-CD20, induces in vivo cytokine release but does not impair ex vivo T-cell responses.

Agarwal A, Vieira CA, Book BK, Sidner RA, Fineberg NS, Pescovitz MD. Agarwal A, et al. Among authors: pescovitz md. Am J Transplant. 2004 Aug;4(8):1357-60. doi: 10.1111/j.1600-6143.2004.00502.x. Am J Transplant. 2004. PMID: 15268740 Free article. Clinical Trial.

8

Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab.

Bearden CM, Agarwal A, Book BK, Sidner RA, Gebel HM, Bray RA, Pescovitz MD. Bearden CM, et al. Among authors: pescovitz md. Hum Immunol. 2004 Aug;65(8):803-9. doi: 10.1016/j.humimm.2004.06.001. Hum Immunol. 2004. PMID: 15336781

9

In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody.

Sidner RA, Book BK, Agarwal A, Bearden CM, Vieira CA, Pescovitz MD. Sidner RA, et al. Among authors: pescovitz md. Hum Antibodies. 2004;13(3):55-62. Hum Antibodies. 2004. PMID: 15598985 Clinical Trial.

10

Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174.

Bearden CM, Agarwal A, Book BK, Vieira CA, Sidner RA, Ochs HD, Young M, Pescovitz MD. Bearden CM, et al. Among authors: pescovitz md. Am J Transplant. 2005 Jan;5(1):50-7. doi: 10.1111/j.1600-6143.2003.00646.x. Am J Transplant. 2005. PMID: 15636611 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page